Chris Varma, Founder of Frontier Medicines

About Chris Varma

Chris Varma is the Co-founder, Chairman, and CEO of Frontier Medicines, a company focused on developing therapies for difficult-to-treat diseases using its chemoproteomics platform. Frontier Medicines recently closed an $80 million Series C funding round. Before co-founding Frontier Medicines, Varma co-founded Blueprint Medicines, which was acquired by Sanofi for over $9 billion in 2025, and Warp Drive Bio, acquired by Revolution Medicines in 2018. He also held senior roles at venture capital firms like MPM Capital, Flagship Pioneering, and Third Rock Ventures.

Chris Varma at a glance

• Company: Frontier Medicines
• Total raised: $80M
• Latest round: Series C
• Investors: Deerfield, RA Capital, Galapagos

More founder profiles (28)

• Christian Itin — Autolus
• Shay Segev — DAZN
• Christian Henry — PacBio
• Sam Bankman-Fried — FTX US
• Dan Vene — iCapital Network
• Nimit Arora — Altos Labs
• Kevin Thompson — SolarWinds
• Yasuyuki Toki — UniFa
• Jeremy Achin — DataRobot
• Marna Cloete — Ivanhoe Mines
• Chuck Cohn — Nerdy
• David Han — StepStone Group
• Steven Hudson — ECN Capital
• Jeff Likosar — ADT
• Praveen Tipirneni — Morphic Therapeutic
• Dani Naveh — Israel Bonds
• David Carruthers — AbbVie
• Rich Zhou — Tuhu
• Patrick Brown — Impossible Foods
• Julian Teicke — wefox
• Andrew Kuper — LeapFrog Investments
• Toru Nishikawa — Preferred Networks
• Roni Al-Dor — Sapiens International Corporation
• Vijay Sharma — One97
• Stuart Aronson — WhiteHorse Finance
• Alan Lee — Gaw Capital Partners
• Pablo Pinto — VistaEnergy
• Merck Mercuriadis — Hipgnosis Songs Fund

Browse related founder lists (4)

• Founders backed by Deerfield
• Founders backed by RA Capital
• Founders backed by Galapagos
• Founders who raised $50M+

Full founder directory · Investor directory · Company funding database · Fundraising library